Inflammation and immunity in ovarian cancer

The standard first-line therapy for ovarian cancer is a combination of surgery and carboplatin/paclitaxel-based chemotherapy. Patients with longer survival and improved response to chemotherapy usually present T-cell inflamed tumours. The presence of tumour-infiltrating T cells (TILs) notably varies...

Descripción completa

Detalles Bibliográficos
Autores principales: Salas-Benito, Diego, Vercher, Enric, Conde, Enrique, Glez-Vaz, Javier, Tamayo, Ibon, Hervas-Stubbs, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569134/
https://www.ncbi.nlm.nih.gov/pubmed/33240443
http://dx.doi.org/10.1016/j.ejcsup.2019.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569134/
https://www.ncbi.nlm.nih.gov/pubmed/33240443
http://dx.doi.org/10.1016/j.ejcsup.2019.12.002

Ejemplares similares